SPI is a pioneer in neurotologic drug development aimed at treating sensorineural diseases of the inner ear.
Our expertise in molecular biology, immunohistochemistry and electrophysiology have lead to the development of preclinical models of hearing loss and tinnitus that are translating into novel and successful clinical trials. Sound Pharmaceuticals, Inc. (SPI) is developing therapeutics that will enable doctors and patient...
SPI is a pioneer in neurotologic drug development aimed at treating sensorineural diseases of the inner ear.
Our expertise in molecular biology, immunohistochemistry and electrophysiology have lead to the development of preclinical models of hearing loss and tinnitus that are translating into novel and successful clinical trials. Sound Pharmaceuticals, Inc. (SPI) is developing therapeutics that will enable doctors and patients to prevent and treat various forms of hearing loss. Sensorineural hearing loss is the third largest disease in the industrialized world and affects 50 million Americans.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.